Alx Oncology Holdings IncALXO
Price (close)
$1.31
Market cap
$181.1M
P/E
—
Revenue (TTM)
—
Net income
-$80.9M
Dividend yield
—
1-year total return
-26.8%
Net margin
—
Revenue growth
—
Debt / equity
0.07x
What Alx Oncology Holdings Inc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.2M | $0 | $0 | — | — | — |
| Net income | -$45.7M | -$83.5M | -$123.5M | -$160.8M | -$134.8M | -$101.7M |
| Free cash flow | -$38.3M | -$68.8M | -$90.7M | -$131.6M | -$122.4M | -$84.4M |
More on ALXO.
- Alx Oncology Holdings Inc summary
- Alx Oncology Holdings Inc financial statements
- Alx Oncology Holdings Inc key metrics
- Alx Oncology Holdings Inc health scores and style box
- Alx Oncology Holdings Inc earnings
- Alx Oncology Holdings Inc dividends
- Alx Oncology Holdings Inc valuation
- Alx Oncology Holdings Inc ownership and insiders
- Alx Oncology Holdings Inc peers
Figures from Alx Oncology Holdings Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.